Mary Szela is Chief Executive Officer and President of TriSalus Life Sciences, Inc. (TLSI). The company reported total compensation of $4,823,349 for fiscal year 2025.
| Salary | $600,920 |
|---|---|
| Bonus | $153,120 |
| Stock awards | $2,570,750 |
| Option awards | $1,482,762 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,797 |
| Total | $4,823,349 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure TriSalus Life Sciences, Inc. filed March 31, 2026, accession 0001628280-26-022124.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and President | $600,920 | $153,120 | $2,570,750 | $1,482,762 | $0 | $0 | $15,797 | $4,823,349 |
| FY2024 | Chief Executive Officer and President | $601,398 | $0 | $1,973,051 | $1,539,500 | $0 | $0 | $22,646 | $4,136,595 |
Totals as disclosed in each year's own compensation disclosure for TriSalus Life Sciences, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mary Szela this page | Chief Executive Officer and President | $4,823,349 |
| David Patience | Chief Financial Officer | $3,443,628 |
| Richard Marshak | Chief Commercial Officer | $1,556,000 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full TriSalus Life Sciences, Inc. compensation brief.
Mary Szela's compensation sits inside TriSalus Life Sciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.